Literature DB >> 21081783

Thyroid carcinoma.

R Michael Tuttle1, Douglas W Ball, David Byrd, Raza A Dilawari, Gerard M Doherty, Quan-Yang Duh, Hormoz Ehya, William B Farrar, Robert I Haddad, Fouad Kandeel, Richard T Kloos, Peter Kopp, Dominick M Lamonica, Thom R Loree, William M Lydiatt, Judith C McCaffrey, John A Olson, Lee Parks, John A Ridge, Jatin P Shah, Steven I Sherman, Cord Sturgeon, Steven G Waguespack, Thomas N Wang, Lori J Wirth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21081783     DOI： 10.6004/jnccn.2010.0093

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  76 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

3.  Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.

Authors:  Aubrey A Carhill; Danielle R Litofsky; Douglas S Ross; Jacqueline Jonklaas; David S Cooper; James D Brierley; Paul W Ladenson; Kenneth B Ain; Henry G Fein; Bryan R Haugen; James Magner; Monica C Skarulis; David L Steward; Mingxhao Xing; Harry R Maxon; Steven I Sherman
Journal:  J Clin Endocrinol Metab       Date:  2015-07-14       Impact factor: 5.958

4.  BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.

Authors:  Mingzhao Xing; Rengyun Liu; Xiaoli Liu; Avaniyapuram Kannan Murugan; Guangwu Zhu; Martha A Zeiger; Sara Pai; Justin Bishop
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

Review 5.  Thyroid cancer in 2010: a roadmap for targeted therapies.

Authors:  Francesca Carlomagno; Massimo Santoro
Journal:  Nat Rev Endocrinol       Date:  2011-02       Impact factor: 43.330

6.  Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.

Authors:  J-W Feng; X-H Yang; B-Q Wu; D-L Sun; Y Jiang; Z Qu
Journal:  Clin Transl Oncol       Date:  2019-03-16       Impact factor: 3.405

Review 7.  Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.

Authors:  Nicholas S Andresen; John M Buatti; Hamed H Tewfik; Nitin A Pagedar; Carryn M Anderson; John M Watkins
Journal:  Eur Thyroid J       Date:  2017-03-23

Review 8.  Evaluation and management of the pediatric thyroid nodule.

Authors:  Jeremy T Guille; Adwoa Opoku-Boateng; Susan L Thibeault; Herbert Chen
Journal:  Oncologist       Date:  2014-12-05

Review 9.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

10.  Variation in the management of thyroid cancer.

Authors:  Megan R Haymart; Mousumi Banerjee; Di Yang; Andrew K Stewart; James C Sisson; Ronald J Koenig; Gerard M Doherty; Jennifer J Griggs
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.